AMYRIS, INC.
EMERYVILLE, CA

AMYRIS, INC., EMERYVILLE

renewable products to the world’s Our story began over a decade ago, when Amyris was founded with a vision of making a positive impact on the world through science. Amyris first used its proprietary process to convert plant-sugars into an alternative, lower cost, stable supply of artemisinin, an effective anti-malarial drug. Thanks to our breakthrough technology, we have stabilized the cost and made accessible the world’s leading treatment for malaria, saving up to one million children a year. We engineer organisms (yeast) through this process and our powerful technology platform so that they take renewably-sourced carbon from plants to make exactly the molecule our customers need to make better products that enable a healthier Earth. Amyris is the only company that has scaled and manufactures new products powered by unique ingredients made accessible by highly engineered organisms that are cost advantaged and are delivering high-performance products for our customers, their consumers and our planet. Today, Amyris is one of the fastest-growing industrial biotechnology companies and is delivering products that are disrupting markets for our customers in several of the world’s largest and rapidly-growing industries. Following successful development of a malaria treatment created by our highly engineered organisms we turned our focus to other areas where we could help solve world problems and support a healthier planet. Through this effort we have leveraged our technology to create disruptive products and also support biopharmaceutical drug discovery and production through our µPharm™ platform. This includes the development of Biofene , Amyris’s brand of renewable farnesene, a long-chain branched hydrocarbon molecule with numerous large-market applications, ranging from cosmetic emollients and fragrances, to fuels, solvents, lubricants, and nutraceuticals. Our products are created by utilizing our highly engineered organisms and sustainably-sourced, renewable sugarcane to create exactly the ingredients that our customers require for products supporting a better, greener world for us and future generations. CNN on Amyris Renewable products derived from sustainable sugarcane from the first Brazil biomaterial producer to receive certification by the Roundtable on Sustainable Biomaterials We are driven to accomplish the seemingly impossible. We use data, feedback and experience to seek powerful solutions to difficult problems facing our customers and the world. We embrace intelligent risk and are a learning organization. We love what we do and love what we make. We are passionate about having a positive impact. We have fun, keep a sense of humor and enjoy working together. We are honest, fair and ethical. We hold ourselves accountable and deliver on our commitments. We do what we say. At Amyris, we are a team of smart, hardworking and creative people who believe in the work we are doing and enjoy each other’s company. We encourage collaboration, learning and straight-up fun while producing quality products and maintaining the highest ethical business standards. Amyris offers its employees a competitive compensation and benefits package. We foster wellness and social involvement through opportunities from healthy onsite lunches and social activities to regular seminars and community outreach. Amyris has pioneered sustainable beauty through biotechnology and supplies cosmetic ingredients to hundreds (and growing) of the world’s leading brands through its Aprinnova joint venture. Amyris’s Biossance direct to consumer brand is one of the fastest-growing independent beauty brands with a focus on providing innovative products that are better for consumers and the planet. In our Flavors & Fragrances business we serve most of the largest fragrances houses in the world commanding, in aggregate, a leading global market share. We are making significant inroads into the food ingredients sector through development of a zero-calorie, sugar-replacement sweetener and human nutrition products to improve the health of people all over the world. Deliver New Innovative Products for Your Customers Access Our Technology to bring Products to Market Faster Compressed new product development cycles are simply a part of beating out the competition. Leverage our technology to accelerate new product development ─ and beat them to market while capturing market share. Where we are Amyris’s headquarters are in Emeryville, California, just a short drive from San Francisco. Our Emeryville location houses our corporate offices, laboratories, and a pilot plant. Our Brazilian operations are headquartered in Campinas and we are building our second production facility adjacent to our first plant now owned by Royal DSM in Brotas in the state of Sao Paulo. Amyris, Inc.

KEY FACTS ABOUT AMYRIS, INC.

Company name
AMYRIS, INC.
Status
Inactive
Filed Number
F15000002269
FEI Number
550856151
Date of Incorporation
May 22, 2015
Home State
DE
Company Type
Foreign for Profit

CONTACTS

Website
http://amyris.com
Phones
(510) 450-0761
(510) 225-2645
(510) 740-7481
(510) 428-1924

AMYRIS, INC. NEAR ME

Principal Address
5885 HOLLIS STREET,
SUITE 100,
EMERYVILLE,
CA,
94608

See Also

Officers and Directors

The AMYRIS, INC. managed by the three persons from EMERYVILLE, Emeryville on following positions: Chief Executive Officer, CFO, Secr

John Melo

Position
Chief Executive Officer Active
From
EMERYVILLE, CA, 94608

Han Kieftenbeld

Position
CFO Active
From
Emeryville, CA, 94608

Nicole Kelsey

Position
Secr Active
From
EMERYVILLE, CA, 94608





Registered Agent is CSC

Address
1201 HAYS STREET, TALLAHASSEE, FL, 32301, 2525

Events

March 19, 2024
REINSTATEMENT
September 22, 2023
REVOKED FOR ANNUAL REPORT
September 28, 2022
REINSTATEMENT
September 23, 2022
REVOKED FOR ANNUAL REPORT

Annual Reports

2022
September 28, 2022
2021
May 3, 2021